BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19162497)

  • 21. [Research progress on pharmacotherapy of calcific aortic valve disease].
    DU M; Ma G; Shi Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):432-438. PubMed ID: 27868419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
    Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
    Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aortic valve calcification: basic science to clinical practice.
    Akat K; Borggrefe M; Kaden JJ
    Heart; 2009 Apr; 95(8):616-23. PubMed ID: 18632833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.
    Novaro GM; Tiong IY; Pearce GL; Lauer MS; Sprecher DL; Griffin BP
    Circulation; 2001 Oct; 104(18):2205-9. PubMed ID: 11684632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Statins in aortic stenosis].
    Dejanović J; Ivanov I
    Med Pregl; 2009; 62 Suppl 3():101-4. PubMed ID: 19702126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcific aortic valve disease: is it another face of atherosclerosis?
    Sathyamurthy I; Alex S
    Indian Heart J; 2015; 67(5):503-6. PubMed ID: 26432749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aortic sclerosis, aortic stenosis and lipid-lowering therapy.
    Rosenhek R; Baumgartner H
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):385-90. PubMed ID: 18327997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin use for nonrheumatic calcific aortic valve stenosis: a review with meta-analysis.
    De Vecchis R; Di Biase G; Esposito C; Ciccarelli A; Cioppa C; Giasi A; Ariano C; Cantatrione S
    J Cardiovasc Med (Hagerstown); 2013 Aug; 14(8):559-67. PubMed ID: 23032960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis?
    Parolari A; Tremoli E; Cavallotti L; Trezzi M; Kassem S; Loardi C; Veglia F; Ferrari G; Pacini D; Alamanni F
    Heart; 2011 Apr; 97(7):523-9. PubMed ID: 21270077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degeneration of native and tissue prosthetic valve in aortic position: do statins play an effective role in prevention?
    Colli A; Gherli T; Mestres CA; Pomar JL
    Int J Cardiol; 2007 Mar; 116(2):144-52. PubMed ID: 16828903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcific aortic stenosis and statin therapy: a new insight.
    Roncalli J; Carrié D; Galinier M
    Int J Cardiol; 2009 Jan; 131(2):275-6; author reply 276-7. PubMed ID: 17825931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiologic mechanisms of calcific aortic stenosis.
    Alexopoulos A; Kaoukis A; Papadaki H; Pyrgakis V
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):71-80. PubMed ID: 22361851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the structural features of symptomatic calcific aortic valve stenosis: A broad-spectrum clinico-pathologic study in 236 consecutive surgical cases.
    Galli D; Manuguerra R; Monaco R; Manotti L; Goldoni M; Becchi G; Carubbi C; Vignali G; Cucurachi N; Gherli T; Nicolini F; Lorusso R; Vitale M; Corradi D
    Int J Cardiol; 2017 Feb; 228():364-374. PubMed ID: 27866029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between calcific aortic stenosis and hypercholesterolemia: is there a need for a randomized controlled trial of cholesterol-lowering therapy?
    Chui MC; Newby DE; Panarelli M; Bloomfield P; Boon NA
    Clin Cardiol; 2001 Jan; 24(1):52-5. PubMed ID: 11195607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reassessment of statins to retard the progression of aortic stenosis.
    Rajamannan NM
    Curr Cardiol Rep; 2007 Apr; 9(2):99-104. PubMed ID: 17430676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Degenerative aortic valve stenosis: looking for a pharmacological prevention].
    Di Fusco SA; Borrelli N; Poli S; Bernelli C; Perone F; Aquilani S; Maggioni AP; Di Pasquale G; Gabrielli D; Oliva F; Colivicchi F
    G Ital Cardiol (Rome); 2023 Apr; 24(4):293-304. PubMed ID: 36971173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve.
    Kutryb-Zajac B; Jablonska P; Hebanowska A; Lango R; Rogowski J; Slominska EM; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1389-1399. PubMed ID: 32126886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcific aortic valve disease should not be considered as a degenerative disease anymore.
    Li YB; Hu CL; Liu J; Tang QZ; Huang CX
    Med Hypotheses; 2007; 68(6):1233-5. PubMed ID: 17011715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation is associated with the remodeling of calcific aortic valve disease.
    Coté N; Mahmut A; Bosse Y; Couture C; Pagé S; Trahan S; Boulanger MC; Fournier D; Pibarot P; Mathieu P
    Inflammation; 2013 Jun; 36(3):573-81. PubMed ID: 23225202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcific aortic valve disease: new concepts.
    Otto CM
    Semin Thorac Cardiovasc Surg; 2010; 22(4):276-84. PubMed ID: 21549267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.